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Acknowledgement and Assurances  
Clemson University acknowledges that the institution received funding under the Coronavirus Response and Relief 
Supplemental Appropriations Act of 2021 (CRRSAA).  Section 314(d)(5) of CRRSAA requires the institution to provide at 
least the same amount of funding in financial aid grants to students as was required to be provided under section 
18004(a)(1) of the CARES Act.  The institution has distributed, or intends to distribute, no less than $6,789,998 in 
emergency financial aid grants to eligible students.   The institution will use its institutional portion of CRRSAA funds in 




Clemson University’s allocation under Section 314(a)(1) of CRRSAA:  





Grants Institutional Portion 
 Clemson University   $       20,323,246   $          6,789,998   $               13,533,248  
 
Total Disbursement of the Institutional Portion of CRRSAA funds: 
CARES Act Funding  
 Total Disbursements 
to Date  
 Clemson University   $                 13,297,068 
 
Type of Institutional Costs pursuant to Section 314(c) of CRRSAA: 
CARES Act Funding  Expense Type  
 Clemson University  
Defray expenses associated with coronavirus and 
recover lost revenues in Auxiliaries (Housing, 
Dining, and Parking Services) 
 
Methodology for Institutional Costs pursuant to Section 314(c) of CRRSAA 
In accordance with the section 314(c) of CRRSAA, Clemson University will use its institutional portion of funds to defray 
expenses associated with coronavirus including recovery of lost revenue, reimbursement for expenses already incurred, 
technology costs associated with a transition to distance education, faculty and staff trainings, and payroll.  The 
institution is currently evaluating costs incurred to date and lost revenue.   
 
 
 
